Purification and immunodetection of the complete recombinant HER-2[neu] receptor produced in yeast

This publication has 29 references indexed in Scilit:

• Beyond trastuzumab: novel therapeutic strategies in HER2-positive metastatic breast cancer
  British Journal of Cancer, 2012
• Quality assessment of HER2 testing by monitoring of positivity rates
  Virchows Archiv, 2011
• Highly Sensitive Detection of HER2 Extracellular Domain in the Serum of Breast Cancer Patients by Piezoelectric Microcantilevers
  Analytical Chemistry, 2011
• Breast cancer prognostic classification in the molecular era: the role of histological grade
  Breast Cancer Research, 2010
• Understanding the HER family in breast cancer: interaction with ligands, dimerization and treatments
  Histopathology, 2010
• The ErbB2 Signaling Network as a Target for Breast Cancer Therapy
  Journal of Mammary Gland Biology and Neoplasia, 2006
• Concordance Between Local and Central Laboratory HER2 Testing in the Breast Intergroup Trial N9831
  JNCI: Journal of the National Cancer Institute, 2002
• Overexpression of ErbB2 in cancer and ErbB2-targeting strategies
  Oncogene, 2000
• Increased expression of the putative growth factor receptor p185HER2 causes transformation and tumorigenesis of NIH 3T3 cells.
  Proceedings of the National Academy of Sciences, 1987
• Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/neuOncogene
  Science, 1987